[1] Aghili Khorasani M. Makhzan ol Advieh Shams Ardakani MR, Rahimi R, Farjadmand F, Eds. Tehran: Sabz-arang and Tehran University of Medical Sciences, 2009.
[2] Tonekaboni M. Rahimi R, Shams Ardakani MR, Farjadmand F, Eds. Tohfat-al-mumenin. Tehran: TMRC, 2007.
[3] Chakravarty N. Inhibition of histamine release from mast cells by nigellone. Ann Allergy. 1993; 70(30): 237-242.
[4] Al-Ghamdi MS. The anti-inflammatory, analgesic and antipyretic activity of Nigella sativa. J Ethnopharmacol. 2001; 76(1): 45-48.
[5] Abdel-Fattah AM, Matsumoto K, Watanabe H. Antinociceptive effects of Nigella sativa oil and its major component, thymoquinone in mice. Eur J Pharmacol. 2000; 400(1): 89-97.
[6] Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res. 2000; 14(5): 323-328.
[7] Gali-Muhtasib H, El-Najjar N, Schneider-Stock R. The medicinal potential of black seed (Nigella sativa) and its components. M.T.H. Khan and A. Ather (Eds.). In: lead molecules from natural products. Amsterdam: Elsevier, 2006.
[8] Gourchian A, Hajimehdipoor H, Ara L, Choopani R, Kamalinejad M, Salimzadeh A, Ghachkar L, Malekfar M. Essential oil and fixed oil content of Nigella sativa after a traditional medicine processing-a comparative study. Biol Forum-An Int J. 2016; 8(2): 120-125.
[9] Amin Gh. Popular medicinal plants of Iran. Tehran: Tehran University of Medical Sciences, 2005.
[10] Al-Jassir MS. Chemical composition and microflora of black cumin (Nigella sativa L.) seeds growing in Saudi Arabia. Food Chem. 1992; 45(4): 239-242.
[11] Atta-Ur-Rahman. Nigellidine-a new indazole alkaloid from the seed of Nigella sativa. Tetrahedron Lett. 1995; 36(12): 1993-1994.
[12] Nickavar B, Mojab F, Javidnia K, Roodgar Amoli MA. Chemical composition of the fixed and volatile oils of Nigella sativa L. from Iran. Z Natrforsch C. 2003; 58(9-10): 629-631.
[13] El Tahrir KE, Ashour MM, al-Harbi MM. The respiratory effects of the volatile oil of the black seed (Nigella sativa) in guinea-pigs: elucidation of the mechanism(s) of action. Gen Pharmacol. 1993; 24(5): 1115-1122.
[14] El Tahrir KEH, Ageel AM. Effect of the volatile oil of Nigella sativa on the arterial blood pressure and heart rate of the guinea-pig. Saudi Pharm J. 1994; 2(4): 163-168.
[15] EL Tahrir Kamal EH, Al-Ajmi MF, Al-Bekairi AM. Some cardiovascular effects of the dethymoquinonated Nigella sativa volatile oil and its major components α-pinene and ρ-cymene in rats. Saudi Pharm J. 2003; 11(3): 104-110.
[16] El-Dakhakhny M. Studies on the Egyptian Nigella sativa some pharmacological properties of the seeds active principle in comparison to its dihydro compound and its polymer. Arzneim Forsch (Drug Res). 1965; 15(10): 1227-1229.
[17] Daba MH, Abdel-Rahman MS. Hepatoprotective activity of thymoquinone in isolated rat hepatocytes. Toxicol Lett. 1998; 95(1): 23-29.
[18] Al-Gharably NM, Badry OA, Nagi MN. Protective effect of thymoquinone against carbon tetrachloride-induced hepatotoxicity in mice. Res Comm Pharmacol Toxicol. 1997; 2(1): 41-50.
[19] Nagi MN, Alam, Badary OA, Al-Shabanah OA, Al-Sawaf HA, Al-Behairy AM. Thymoquinone protects against CCl4-hepatotoxicity in mice via an antioxidant mechanism. Biochem Mol Bio Int. 1999; 47(1); 153-159.